Unlocking New Hope: Immunotherapy for Lung Cancer

immunotherapy for lung cancer

Lung cancer remains a formidable challenge, but immunotherapy offers new hope by harnessing the body’s immune system to combat cancer cells. Traditional treatments like surgery, radiation, and chemotherapy often fall short for advanced cases. Immunotherapy, including checkpoint inhibitors like pembrolizumab (Keytruda) and nivolumab (Opdivo), personalized vaccines, and CAR-T cell therapy, provides innovative alternatives. CAR-NK cell therapy is emerging as a promising option with fewer side effects. Ongoing clinical trials, such as CheckMate 227, explore combining immunotherapy with other treatments to improve outcomes. As research advances, immunotherapy aims to revolutionize lung cancer therapy, enhancing survival rates and quality of life.